Department of Population and Quantitative Health Sciences, University of Massachusetts Medical School, Worcester, MA, USA.
Learning Health Systems, Department of Internal Medicine, Wake Forest University School of Medicine, Winston-Salem, NC, USA.
J Altern Complement Med. 2021 Feb;27(2):168-175. doi: 10.1089/acm.2020.0254. Epub 2020 Dec 8.
Medication nonadherence contributes to poor blood pressure control and increases cardiovascular disease risk in patients with hypertension. Identifying modifiable risk factors for low or nonadherence to antihypertensive medication is needed. Studies that have examined the relationship between herbal or dietary supplement (HDS) use and antihypertensive medication nonadherence provide inconsistent findings. Data from the National Health and Nutrition Examination Survey were used to examine the association between HDS use, current use of prescribed antihypertensive medication, and blood pressure status. The study sample included hypertensive adults ( = 5,478) who have been told by a health professional to take prescribed medication for their health condition. Respondents were classified as either HDS users or HDS nonusers. Depending on the kind of supplement used, HDS users were further divided into three mutually exclusive groups: hypertension HDS users, nonhypertension HDS users, and those who used both kinds of supplements. Supplements groupings were based on reports in the literature. Blood pressure status definition was based on Eighth Joint National Committee (JNC 8) recommendations. Adjusted odds ratios (aORs) and 95% confidence intervals (95% CIs) were obtained from logistic models. Overall HDS use prevalence was 62%. Current medication use did not significantly differ between patients reporting no HDS use and those reporting HDS use (aOR: 1.45; 95% CI: 0.78-2.69). No observable differences were found in current medication use between patients reporting no HDS use and those taking nonhypertension HDS or both kinds of supplements. Use of hypertension HDS was associated with improved blood pressure (aOR: 1.90; 95% CI: 1.07-3.36) compared with no HDS use. In a nationally representative U.S. sample, HDS use did not compromise current use of prescribed medication and was associated with improved blood pressure control. More research is needed to better understand why HDS use is associated with better blood pressure control.
药物依从性差会导致高血压患者的血压控制不佳,增加心血管疾病风险。因此,需要确定可改变的导致降压药物低依从性或不依从性的风险因素。已有的研究考察了草药或膳食补充剂(HDS)使用与降压药物不依从性之间的关系,但结果并不一致。本研究利用美国国家健康和营养调查的数据,考察了 HDS 使用、当前使用处方降压药物与血压状况之间的关系。研究样本包括被专业医务人员告知需服用处方药治疗的高血压成年人( = 5478 人)。将受访者分为 HDS 使用者和 HDS 非使用者。根据使用的补充剂类型,HDS 使用者进一步分为三组:高血压 HDS 使用者、非高血压 HDS 使用者和同时使用两种补充剂的人群。补充剂分组基于文献报道。血压状况的定义基于第八届联合国家委员会(JNC 8)的建议。使用逻辑回归模型获得调整后的比值比(aOR)和 95%置信区间(95%CI)。总体 HDS 使用的流行率为 62%。报告未使用 HDS 和使用 HDS 的患者的当前药物使用情况无显著差异(aOR:1.45;95%CI:0.78-2.69)。报告未使用 HDS 和使用非高血压 HDS 或同时使用两种补充剂的患者的当前药物使用情况无明显差异。与未使用 HDS 相比,使用高血压 HDS 与血压改善相关(aOR:1.90;95%CI:1.07-3.36)。在一个具有全国代表性的美国样本中,HDS 使用并未影响当前处方药物的使用,并且与改善血压控制有关。需要进一步研究以更好地理解为什么 HDS 使用与更好的血压控制相关。